72 related articles for article (PubMed ID: 77217)
1. [Bromocriptine, a new therapeutic principle in prostatic adenoma and carcinoma. Basis, possibilities, limits].
Jacobi GH; Altwein JE
Dtsch Med Wochenschr; 1978 May; 103(19):827-33. PubMed ID: 77217
[No Abstract] [Full Text] [Related]
2. [Bromocryptin, a new therapeutic principle in adenoma and carcinoma of the prostate. Presuppositions, possibilities and limitations].
Jacobi GH; Altwein JE
Minerva Urol; 1980; 32(3):167-73. PubMed ID: 6159524
[No Abstract] [Full Text] [Related]
3. The effect of ergobromocriptine on serum testosterone and prolactin levels in patients with carcinoma of the prostate.
Taşar C; Akdaş A; Kirkali Z
Int Urol Nephrol; 1986; 18(1):71-4. PubMed ID: 2424860
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of prostatic carcinoma with phostrolin and bromocriptine while monitoring serum concentrations of testosterone and prolactin].
Jeromin L
Pol Tyg Lek; 1980 Mar; 35(10):359-62. PubMed ID: 7367321
[No Abstract] [Full Text] [Related]
5. Clinical trial of 2-bromo-alpha-ergocryptine (NSC-169774) in human prostatic cancer.
Coune A; Smith P
Cancer Chemother Rep; 1975; 59(1):209-13. PubMed ID: 1093667
[TBL] [Abstract][Full Text] [Related]
6. [Prolactin and cancer of the prostate. IV. Prolactin inhibition in the treatment of prostatic cancer].
Maganto Pavón E; Mayayo Dehesa T; Mateos Torres JA; Boronat Tormo F; Verdú Tartajo F; de Blas Gómez V
Arch Esp Urol; 1982; 35(5):312-25. PubMed ID: 6758710
[No Abstract] [Full Text] [Related]
7. [Prolactin and prostatic cancer. Modification of testosterone serum levels in estrogen-induced hyperprolactinemia by bromocriptine].
Maganto E; Mayayo T; Mateos JA; Verdú F; Escudero Barrilero A
Actas Urol Esp; 1983; 7(4):289-94. PubMed ID: 6624577
[No Abstract] [Full Text] [Related]
8. The effect of antiestrogen, antiandrogen, and the prolactin inhibitor 2 bromo-alpha-ergocriptine on the stromal tissue of human benign prostatic hyperplasia. Correlation of stereological data and plasma hormones.
Bartsch G; Oberholzer M; Rohr HP
Invest Urol; 1981 Jan; 18(4):308-12. PubMed ID: 6161105
[TBL] [Abstract][Full Text] [Related]
9. [Bromocriptine and prostatic carcinoma: testosterone metabolism in relation to tumor grading (author's transl)].
Jacobi GH; Kurth KH; Altwein JE
Urologe A; 1979 Mar; 18(2):91-8. PubMed ID: 433016
[TBL] [Abstract][Full Text] [Related]
10. The serum levels of testosterone and prolactin in patients with prostatic carcinoma treated with various doses of Fostrolin and bromocriptin.
Jeromin L
Int Urol Nephrol; 1982; 14(1):51-6. PubMed ID: 6889585
[TBL] [Abstract][Full Text] [Related]
11. [Value of testosterone, FSH and LH on plasma in patients with prostatic adenoma and carcinoma before and after different hormonal treatments].
Garcia de la Peña E; Ramos F; Horcajada C; Cifuentes Delatte L; Vivanco F
Rev Clin Esp; 1978 Jan; 148(1):19-23. PubMed ID: 76325
[No Abstract] [Full Text] [Related]
12. [Clinical experience with single and multiple subcutaneous administration of LHRH analog Buserelin (Hoe 766) in prostatic carcinoma: endocrinological study of optimum subcutaneous doses].
Niijima T; Isurugi K; Kawabe K; Kinoshita K; Asano M; Nakauchi K; Fujita K; Nishimura Y; Nitoh H; Yokoyama M
Hinyokika Kiyo; 1988 Jul; 34(7):1297-307. PubMed ID: 2459944
[TBL] [Abstract][Full Text] [Related]
13. [Increased secretion of prolactin after inhibition of dopaminergic receptors by metoclopramide in patients with cancer of the prostate].
Baranowska B; Jeske W; Szymanowski J; Piechna K
J Urol (Paris); 1983; 89(8):601-5. PubMed ID: 6203986
[TBL] [Abstract][Full Text] [Related]
14. [Bromocriptine (CB 154) in the treatment of prostatic adenoma].
Serment G; Roulier R; Martin P
Nouv Presse Med; 1977 Apr; 6(13):1147-8. PubMed ID: 66667
[No Abstract] [Full Text] [Related]
15. Successful treatment of a prolactin-producing pituitary macroadenoma with intravaginal bromocriptine mesylate: a novel approach to intolerance of oral therapy.
Katz E; Schran HF; Adashi EY
Obstet Gynecol; 1989 Mar; 73(3 Pt 2):517-20. PubMed ID: 2915884
[TBL] [Abstract][Full Text] [Related]
16. [Bromocriptine for palliation of advanced prostatic carcinoma. Experimental and clinical profile of a drug (author's' transl)].
Jacobi GH; Altwein JE
Urol Int; 1979; 34(4):266-90. PubMed ID: 89747
[TBL] [Abstract][Full Text] [Related]
17. Combined anti-prolactin and anti-oestrogen therapy for breast carcinoma.
Ward HW
Clin Oncol; 1977 Mar; 3(1):91-5. PubMed ID: 862280
[No Abstract] [Full Text] [Related]
18. Bromocriptine update.
Borowski GD; Rose LI
Am Fam Physician; 1984 Aug; 30(2):218-20. PubMed ID: 6464960
[No Abstract] [Full Text] [Related]
19. Bromocriptine.
Sherman BM; Chapler FK
J Iowa Med Soc; 1980 May; 70(5):209-10, 212. PubMed ID: 7189202
[No Abstract] [Full Text] [Related]
20. Dopamine agonists in the treatment of hyperprolactinemia. Comparison between bromocriptine and lisuride.
Stracke H; Heinlein W; Horowski R; Schatz H
Arzneimittelforschung; 1986 Dec; 36(12):1834-6. PubMed ID: 3566845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
